Novavax pays to settle covid-19 vaccine dispute
Novavax has agreed deals to distribute its covid-19 vaccine in Korea, Japan, UK as well as in developing countries (Credit: Shutterstock/Mongkolchon Akesin)
US biotech company Novavax has agreed to pay US$400 million to settle an ICC claim brought by global health organisation Gavi over a cancelled contract to supply covid-19 vaccines to low and middle-income countries.
To read more
Subscribe to Global Arbitration Review
Subscribe to unlock unlimited access
Get news, unique commentary, expert analysis and essential resources from the Global Arbitration Review experts.
Subscribe now